Conclusion
Overexpression/amplificatio n of Her-2/Neu increases angiogenesis in breast cancer. Her-2/Neu amplification is seen in bone marrow micrometastatic cells and correlates with Her-2/Neu amplification in primary tumour. The proangiogenic effect of Her2/Neu may represent metastatic progression in bone marrow micrometastases and may therefore be a potential target for the treatment of micrometastatic disease.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tormey, S., Curran, C. & Given, H.F. Correlation of Her-2/Neu detection and angiogenesis in breast cancer — Proposed role in micrometastatic progression. Ir J Med Sci 171 (Suppl 1), 19 (2002). https://doi.org/10.1007/BF03170361
DOI: https://doi.org/10.1007/BF03170361